论文部分内容阅读
原发性肝癌是我国最常见的恶性肿瘤之一,病程发展快,患者就诊时往往已是中晚期,目前尚无根治或特效的治疗方案。现阶段手术、肝动脉栓塞化疗、局部消融是针对肝癌的主要治疗手段,但是术后复发率高、生存质量降低、对免疫系统造成的损害等使得目前的各种治疗手段仍无法从根本上改变肝癌的预后,亟待研究更为有效的方法用于肝癌的治疗。众所周知,乙型肝炎、丙型肝炎是肝癌最重要的病因之一,而我国乙型肝炎病毒携带者比例高,有着庞大的乙型肝炎感染发病人群。抗病毒治疗是治疗慢性乙型肝炎和丙型肝炎的关键,但目前抗病毒治疗方案存在如下缺陷:(1)目前针对慢性乙
Primary liver cancer is one of the most common malignant tumors in our country. The course of the disease is developing rapidly. The patients are often in the middle and late stages of treatment. There is no cure or cure for the disease. At this stage of surgery, hepatic arterial chemoembolization and local ablation are the main treatments for liver cancer. However, the high postoperative recurrence rate, the low quality of life and the damage to the immune system make the current various treatment methods can not fundamentally change The prognosis of liver cancer, an urgent need to study more effective method for the treatment of liver cancer. As we all know, hepatitis B, hepatitis C is one of the most important causes of liver cancer, and the high proportion of carriers of hepatitis B virus in our country, with a huge population of hepatitis B infection. Antiviral therapy is the key to the treatment of chronic hepatitis B and hepatitis C, but the current antiviral treatment programs have the following defects: (1) At present, chronic B